Narrow Results Clear All
- Audiovisual 3
- Book/Report 1
- Legislation/Regulation 6
- Tools/Toolkit 8
- Web Resource 58
- Award 11
- Grant 3
- Meeting/Conference 1
- Press Release/Announcement
- Communication Improvement 13
- Culture of Safety 5
- Education and Training 25
- Error Reporting and Analysis 21
- Human Factors Engineering 24
- Legal and Policy Approaches 23
- Logistical Approaches 1
- Quality Improvement Strategies 28
- Research Directions 1
- Specialization of Care 1
- Teamwork 2
- Technologic Approaches 7
- Device-related Complications 19
- Diagnostic Errors 5
- Discontinuities, Gaps, and Hand-Off Problems 2
- Drug shortages 3
- Identification Errors 2
- Medical Complications 9
- Medication Errors/Preventable Adverse Drug Events 48
- MRI safety 4
- Nonsurgical Procedural Complications 3
- Surgical Complications 4
- Transfusion Complications 1
- Internal Medicine 22
- Nursing 3
- Pharmacy 39
- Family Members and Caregivers 1
- Health Care Executives and Administrators 63
Health Care Providers
- Nurses 12
- Pharmacists 16
- Physicians 19
Non-Health Care Professionals
- Media 4
- Patients 26
- Africa 1
- Asia 1
- Australia and New Zealand 1
- Central and South America 1
- Europe 4
- Canada 3
- United States of America 113
Search results for "Health Care Providers"
- Press Release/Announcement
- Health Care Providers
FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; November 14, 2018.
This safety announcement raises awareness of pump failures, dosing errors, and other potential safety issues associated with implanted pumps. Recommendations to enhance safety include review of medication labeling to select appropriate medicines and concentrations as well as open discussions with patients about risks associated with pump and medication options.
Palo Alto, CA: Gordon and Betty Moore Foundation; November 1, 2018.
Missed or delayed diagnoses lead to delays in care and significant preventable harm for patients. Despite an increasing focus on diagnostic error, accurate measurement and implementation of effective strategies for mitigating its adverse effects remain challenging. The Gordon and Betty Moore Foundation recently announced a new $85 million initiative focused on diagnostic excellence that takes into account health care costs, timeliness, and individual patient needs. This initiative will focus on three clinical areas including cancer, infections, and cardiovascular events. Through this funding, the foundation hopes to stimulate novel approaches to measuring diagnostic performance and plans to assess the effectiveness of new technologies in improving the diagnostic process. A PSNet perspective highlighted ongoing challenges related to diagnostic error.
Oakbrook Terrace, IL: Joint Commission.
Insufficient test result follow-up is a known contributor to diagnostic error. Although critical test result communications is a National Patient Safety Goal, practices covering all levels of test results must be held to similar standards. The Joint Commission is requesting field insights regarding timely follow up of all test results. The deadline to submit comments is December 15, 2018.
Canadian Patient Safety Institute.
Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.
Silver Spring, MD: US Food and Drug Administration; September 29, 2018.
Washington DC: National Academy of Medicine and the Aspen Institute.
Despite increased awareness regarding the public health impacts of opioid misuse and overdose in the United States, the complexity of the problem has hindered the effectiveness of improvement efforts. This website highlights the work of a multiorganizational collaborative to explore systemic solutions to address the opioid crisis. An Annual Perspective discussed the impact of the opioid epidemic on patient safety.
Horsham, PA: Institute for Safe Medication Practices; July 26, 2018.
Institute for Safe Medication Practices.
Horsham, PA: Institute for Safe Medication Practices; 2018.
Results from this survey will inform the revision of a high-alert medication list used to raise awareness about drugs that have heightened potential to cause patient harm if used incorrectly.
Safe handling of concentrated electrolyte products from outsourcing facilities during critical drug shortages.
National Alert Network. Horsham, PA: Institute for Safe Medication Practices; Bethesda, MD: American Society of Health-System Pharmacists. May 24, 2018.
Drug shortages can necessitate hospitals to find alternative sources for important medications. This alert raises awareness of risks associated with potassium chloride use due to variations in labeling, packaging, or concentration of outsourced medications. Recommendations include use of barcode scanning and communicating with staff regarding drug shortages.
Bethesda, MD: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. May 21, 2018. PA-18-790; PA-18-791.
The Institute for Safe Medication Practices.
Structured interaction with a wide variety of experts and environments enables medication safety improvement. This 2-week educational program provides international clinicians with the opportunity to work with leaders based in the United States to engage in incident analysis, project design, and strategic planning to enhance medication safety efforts in their home countries.
Food and Drug Administration, Institute for Safe Medication Practices.
This fellowship program provides clinicians with learning opportunities at the Institute for Safe Medication Practices and the US Food and Drug Administration. The appointment consists of a pair of successive 6-month positions designed to provide experience in both system improvement and regulatory approaches to enhance medication safety. The process for submitting applications is now closed.
Joint Commission. March 12, 2018.
The Eisenberg Award honors individuals and organizations who have made unique and sustained contributions to the work of patient safety and quality improvement. The 2017 honorees are Dr. Thomas Gallagher; Children's Hospitals' Solutions for Patient Safety; and LifePoint Health's National Quality Program, Brentwood, Tennessee. The awards were presented at the National Quality Forum annual conference on March 12, 2018 in Washington, DC.
Institute for Safe Medication Practices.
FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 11, 2018.
National Alert Network. Horsham, PA: Institute for Safe Medication Practices; Bethesda, MD: American Society of Health-System Pharmacists. October 12, 2017.
Care devices that enable patients to administer medicines at home can have unintended consequences. This alert raises awareness of hazards related to insulin pen misuse and offers recommendations to reduce risks, such as training patients to properly use pen needles and engaging community pharmacists in verifying that patients understand appropriate administration techniques.
Horsham, PA: Institute for Safe Medication Practices; 2017.
High-alert medications have the potential to cause substantial patient harm if administration mistakes occur. This assessment tool will enable organizations across a range of care environments to determine opportunities for improvement in 11 high-alert medication categories. In addition, the tool provides an opportunity for organizations to submit their data anonymously to a national data collection effort led by the Institute for Safe Medication Practices to define the current state of high-alert medication practices in health care. The data submission process is now closed.
Horsham, PA: Institute for Safe Medication Practices; August 24, 2017.
Horsham, PA: Institute for Safe Medication Practices; January 11, 2017.